The EMS Group, with its companies combined in the EMS-CHEMIE HOLDING AG and globally active in the business areas High Performance Polymers and Specialty Chemicals, increased net sales in the first three months of 2022 by 12.7% compared to the previous year to reach CHF 638 million (566). In local currencies net sales exceeded those of the previous year by 15.0%.
more
The EMS Group, with its companies combined in the EMS-CHEMIE HOLDING AG, and globally active in the business areas High Performance Polymers and Specialty Chemicals, increased net sales in 2021 by 25.1% and net operating income by 24.3% compared to the previous year. In this way, net sales, net operating income and net income were considerably higher than the values achieved before the pandemic and, adjusted to currency influences, are new record levels in the more than 85 years of company history.more
The EMS Group, with its companies combined in the EMS-CHEMIE HOLDING AG and globally active in the business areas High Performance Polymers and Specialty Chemicals, increased net sales in the first nine months of 2021 to CHF 1,691 million (1,296) which is 30.5% higher than previous year. Net sales in the third quarter were again higher than before the pandemic. more
On July 16, 2021 the EMS Group published its provisional half-year report 2021. The definitive consolidated half-year report is now available, based on the individual financial statements of the affiliated companies as at June 30, 2021. The definitive half-year report shows no significant changes to the provisional report.more
The invitation from the EMS-CHEMIE HOLDING AG was followed on August 7, 2021 by a large gathering of 1,655 people. This makes EMS the first company listed on the stock exchange to organise its Annual General Meeting after the Corona pandemic as a major event again. Following guidelines from the Swiss Federal Council for major events, entry was only possible with a valid Covid-19 certificate. The largest mobile rapid testing infrastructure in Switzerland was installed for shareholders without a valid Covid-19 certificate. more